• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢和减重手术患者发生肺栓塞的预测因素:来自最新MBSAQIP数据的见解

Predictive Factors for Pulmonary Embolism in Patients Undergoing Metabolic and Bariatric Surgery: Insights from the Latest MBSAQIP Data.

作者信息

Manueli Laos Emiliano G, Fontaine-Nicola Andres, Zhang Lily, Berger Reed, Abdelhady Khaled, Schlottmann Francisco, Masrur Mario A

机构信息

Department of Surgery, Division of General, Minimally Invasive & Robotic Surgery, University of Illinois at Chicago, Chicago, IL, USA.

Division of Cardiothoracic surgery, University of Illinois at Chicago, Chicago, United States.

出版信息

Obes Surg. 2025 Sep 1. doi: 10.1007/s11695-025-08190-z.

DOI:10.1007/s11695-025-08190-z
PMID:40889062
Abstract

INTRODUCTION

Obesity is a major risk factor for many diseases, including cardiovascular disease and cancer, among others. While metabolic and bariatric surgery (MBS) is an effective treatment, pulmonary embolism (PE) remains a concern due to factors like Virchow's triad exacerbated by excess adipose tissue. This study aims to identify perioperative risk factors for PE in patients undergoing MBS to help reduce its incidence.

METHODS

This study retrospectively analyzed the MBSAQIP PUF database of the year 2023 to identify risk factors for PE within 30 days of sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).

RESULTS

A total of 200865 MBS patients (133,620 SG, 67,245 RYGB) were included in the study; the incidence of 30-day postoperative PE was 0.1% for SG and 0.12% for RYGB. For SG, significant PE risk factors included age, BMI, Black/African American race, history of PE, immunosuppressive therapy, and heart failure. For RYGB, risk factors were age, Black/African American race, history of PE/VTE, dialysis, need for surgical conversion, and mechanical-only VTE prophylaxis.

CONCLUSION

PE is a rare but potentially fatal post-bariatric surgery complication. The most important risk factor was previous history of thromboembolic events in both cohorts. Individualized risk assessment requires further prospective studies.

摘要

引言

肥胖是包括心血管疾病和癌症等多种疾病的主要危险因素。虽然代谢和减重手术(MBS)是一种有效的治疗方法,但由于过多脂肪组织加剧了诸如维勒三联征等因素,肺栓塞(PE)仍然是一个令人担忧的问题。本研究旨在确定接受MBS手术患者围手术期发生PE的危险因素,以帮助降低其发生率。

方法

本研究回顾性分析了2023年MBSAQIP PUF数据库,以确定袖状胃切除术(SG)或Roux-en-Y胃旁路术(RYGB)后30天内发生PE的危险因素。

结果

本研究共纳入200865例MBS患者(133620例SG,67245例RYGB);SG术后30天PE发生率为0.1%,RYGB为0.12%。对于SG,PE的显著危险因素包括年龄、BMI、黑人/非裔美国人种族、PE病史、免疫抑制治疗和心力衰竭。对于RYGB,危险因素为年龄、黑人/非裔美国人种族、PE/VTE病史、透析、手术转换需求和仅采用机械性VTE预防措施。

结论

PE是减重手术后一种罕见但可能致命的并发症。两个队列中最重要的危险因素都是既往血栓栓塞事件史。个体化风险评估需要进一步的前瞻性研究。

相似文献

1
Predictive Factors for Pulmonary Embolism in Patients Undergoing Metabolic and Bariatric Surgery: Insights from the Latest MBSAQIP Data.代谢和减重手术患者发生肺栓塞的预测因素:来自最新MBSAQIP数据的见解
Obes Surg. 2025 Sep 1. doi: 10.1007/s11695-025-08190-z.
2
Development of venous thromboembolic event risk calculator for metabolic and bariatric surgery patients to reduce mortality.为降低代谢和减重手术患者的死亡率而开发静脉血栓栓塞事件风险计算器。
Surg Obes Relat Dis. 2025 Mar;21(3):228-239. doi: 10.1016/j.soard.2024.09.007. Epub 2024 Oct 15.
3
Bariatric surgery in patients with preoperative therapeutic anticoagulation: a 2015-2021 MBSAQIP database study.术前抗凝治疗患者的减重手术:2015-2021 年 MBSAQIP 数据库研究。
Surg Obes Relat Dis. 2024 Dec;20(12):1260-1269. doi: 10.1016/j.soard.2024.07.018. Epub 2024 Aug 8.
4
Surgical, metabolic, and prognostic outcomes for Roux-en-Y gastric bypass versus sleeve gastrectomy: a systematic review.Roux-en-Y 胃旁路术与袖状胃切除术的手术、代谢和预后结局:系统评价。
Surg Obes Relat Dis. 2021 Dec;17(12):2097-2106. doi: 10.1016/j.soard.2021.06.020. Epub 2021 Jul 7.
5
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
6
Evaluating postoperative conversion trends in the elderly: an Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program-based analysis of bariatric surgery outcomes.评估老年人术后转归趋势:基于代谢与减重手术认证及质量改进项目的减重手术结果分析
Surg Obes Relat Dis. 2025 Aug;21(8):949-955. doi: 10.1016/j.soard.2025.04.002. Epub 2025 Apr 14.
7
Pregnancy and birth complications among women undergoing bariatric surgery: sleeve gastrectomy versus Roux-en-Y gastric bypass.接受减肥手术的女性的妊娠和分娩并发症:袖状胃切除术与Roux-en-Y胃旁路术的比较
Surg Obes Relat Dis. 2025 Apr;21(4):509-515. doi: 10.1016/j.soard.2024.11.012. Epub 2024 Dec 16.
8
Association of inferior vena cava filter placement with perioperative outcomes after bariatric surgery: a contemporary analysis of 721,161 patients.减重手术后下腔静脉滤器置入与围手术期结局的关联:对721,161例患者的当代分析
Surg Obes Relat Dis. 2025 Jul 30. doi: 10.1016/j.soard.2025.07.009.
9
​​Long-Term Outcomes in Sleeve Gastrectomy versus Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis of Randomized Trials.袖状胃切除术与Roux-en-Y胃旁路术的长期疗效:随机试验的系统评价和荟萃分析
Obes Surg. 2025 Jul 7. doi: 10.1007/s11695-025-08044-8.
10
Comparative Analysis of the Incidence of Post-bariatric Cholelithiasis in Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.袖状胃切除术和Roux-en-Y胃旁路术后肥胖症后胆石症发病率的比较分析
Obes Surg. 2025 Jul 7. doi: 10.1007/s11695-025-08020-2.

本文引用的文献

1
Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management.肥胖与心血管风险更新:从病理生理学到临床管理。
Nutrients. 2024 Aug 20;16(16):2781. doi: 10.3390/nu16162781.
2
Disparities in Bariatric Surgery Outcomes: A Regional Analysis.减重手术结局的差异:区域分析。
Obes Surg. 2024 Oct;34(10):3848-3856. doi: 10.1007/s11695-024-07470-4. Epub 2024 Aug 28.
3
Bariatric and general surgical procedures in obese patients with a history of venous thromboembolism and concurrent anticoagulation therapy.
肥胖患者静脉血栓栓塞病史和同时抗凝治疗的减重和普通外科手术。
Cir Cir. 2024;92(4):475-480. doi: 10.24875/CIRU.23000190.
4
Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses.内镜、手术和药物肥胖治疗的成本效益:微观模拟和阈值分析。
Gut. 2023 Nov 24;72(12):2250-2259. doi: 10.1136/gutjnl-2023-330437.
5
Factors Associated with Increased Risk for Pulmonary Embolism After Metabolic and Bariatric Surgery: Analysis of Nearly One Million Patients.代谢和减重手术后肺栓塞风险增加的相关因素:近100万患者的分析
Obes Surg. 2022 Jul;32(7):2433-2437. doi: 10.1007/s11695-022-06102-z. Epub 2022 May 14.
6
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.托法替尼治疗类风湿关节炎与心血管和癌症风险。
N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927.
7
The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery.美国代谢与减重外科学会(ASMBS)关于减重手术围手术期静脉血栓栓塞预防的最新立场声明。
Surg Obes Relat Dis. 2022 Feb;18(2):165-174. doi: 10.1016/j.soard.2021.10.023. Epub 2021 Nov 10.
8
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.肥胖与心血管疾病:美国心脏协会科学声明
Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22.
9
Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study.糖皮质激素的使用与首次和复发性静脉血栓栓塞风险:自身对照病例系列和队列研究。
Br J Haematol. 2021 Jun;193(6):1194-1202. doi: 10.1111/bjh.17388. Epub 2021 Mar 21.
10
Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies.腹部肥胖与心血管疾病风险:31项前瞻性研究的剂量反应荟萃分析。
Br J Nutr. 2021 Nov 14;126(9):1420-1430. doi: 10.1017/S0007114521000064. Epub 2021 Jan 12.